… We will further assess the impact of current vaccination programs on screening. … molecular
markers in view of their use in triage assays, emphasizing epigenetic and protein markers. …

… of these markers are presented in the context of improved cervical disease detection and …
Molecular markers of cervical squamous cell cancer precursor lesions. J Gynec Oncol. 2006…

… molecular markers to existing screening technologies. Immunohistochemistry markers applied
to the traditional cervical … cervical screening test: characteristics of a cost-effective test for …

The dissection and mapping of cervical carcinogenesis consequent to human papillomavirus
(HPV)-induced molecular alterations have yielded a series of biomarkers that potentially …

… to the introduction of cervical screening. Cervical screening currently depends on the
identification by cytology of abnormalities in cells taken from the surface of the cervix. The standard …

… Up to a quarter of all patients may have a false-negative result on the basis of cervical … and
molecular markers and their clinical relevance. HPV testing and surrogate molecular markers …

… where women have access to cervical cytology and subsequent … screening tool, on a single
test basis it is not highly effective as a primary screening modality in the detection of cervical …

… molecular markers for detecting this transition. Such markers might be combined with existing
screening … Proteomic methodologies provide a general route to biomarker discovery. They …

Cervical cancer is one of the most common cancers in women and can be routinely
screened for by the Papanicolaou smear. Screening for HPV high-risk types 16 and 18 has …

… Molecular markers that are currently available and can be assessed in the original sample,
but also … The advantages could circumvent some of the main barriers to cervical screening in …